Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET)

De Silva, Deidre A.; Fink, John N.; Davis, Stephen M.; Christensen, Soren; Ebinger, Martin; Bladin, Christopher; Levi, Christopher R.; Parsons, Mark; Butcher, Ken; Barber, P. Alan; Donnan, Geoffrey A.

Title: Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET)
Creator: De Silva, Deidre A.; Fink, John N.; Davis, Stephen M.; Christensen, Soren; Ebinger, Martin; Bladin, Christopher; Levi, Christopher R.; Parsons, Mark; Butcher, Ken; Barber, P. Alan; Donnan, Geoffrey A.
Relation: Stroke Vol. 40, Issue 8, p. 2872-2874
Publisher Link: http://dx.doi.org/10.1161/STROKEAHA.108.543595
Publisher: Lippincott Williams & Wilkins
Resource Type: journal article
Date: 2009
Description: Reperfusion and recanalization have both been used as surrogate markers of clinical outcome in trials of stroke thrombolysis. We aimed to prove that the beneficial impact of recanalization with intravenous tissue plasminogen activator on clinical outcomes is attributable to reperfusion in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET). EPITHET was a prospective, randomized, placebo-controlled trial of intravenous tissue plasminogen activator in the 3- to 6-hour window. Reperfusion was defined as >90% reduction in magnetic resonance perfusion-weighted imaging lesion volume and recanalization as improvement of MR angiographic Thrombolysis In Myocardial Infarction grading by ≥2 points from baseline to Day 3 to 5. At Day 3 to 5, reperfusion and recanalization with intravenous tissue plasminogen activator were strongly correlated. Reperfusion was associated with improved clinical outcome independent of whether recanalization occurred. In contrast, recanalization was not associated with clinical outcome when reperfusion was included as a covariate in regression analyses. Reperfusion is a surrogate marker of clinical outcomes independent of recanalization based on the criteria applied in EPITHET. The impact of recanalization on clinical outcomes was attributable to reperfusion.
Subject: clinical outcomes; ischemic stroke; recanalization; reperfusion; thrombolysis
Identifier: uon:8112
Identifier: http://hdl.handle.net/1959.13/916787
Identifier: ISSN:0039-2499
Reviewed

Hits: 4489
Visitors: 4419
Downloads: 0

		Thumbnail	File	Description	Size	Format